These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 39344839)

  • 1. Glycaemic control metrics and metabolic dysfunction-associated steatotic liver disease in children and adolescents with type 1 diabetes.
    Maffeis C; Piona C; Morandi A; Marigliano M; Morotti E; Mancioppi V; Caiazza E; Zusi C; Emiliani F; Mantovani A; Colecchia A; Targher G
    Diabetes Obes Metab; 2024 Dec; 26(12):5896-5905. PubMed ID: 39344839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood glucose control and metabolic dysfunction-associated steatotic liver disease in people with type 1 diabetes.
    Della Pepa G; Lupoli R; Masulli M; Boccia R; De Angelis R; Gianfrancesco S; Piccolo R; Rainone C; Rivellese AA; Annuzzi G; Bozzetto L
    J Endocrinol Invest; 2024 Sep; 47(9):2371-2378. PubMed ID: 38498227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic dysfunction-associated steatotic liver disease is associated with worse time in ranges in type 1 diabetes.
    Aernouts C; Beldé SPW; Lambrechts J; Mertens J; Ledeganck KJ; Francque SM; De Block CEM
    Diabetes Obes Metab; 2024 Sep; 26(9):3781-3790. PubMed ID: 38924290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poorly controlled pediatric type 1 diabetes mellitus is a risk factor for metabolic dysfunction associated steatotic liver disease (MASLD): An observational study.
    Koutny F; Wiemann D; Eckert A; Meyhöfer S; Fritsch M; Pappa A; Wiegand S; Weyer M; Wurm M; Weghuber D; Holl RW
    J Pediatr Gastroenterol Nutr; 2024 May; 78(5):1027-1037. PubMed ID: 38558281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence and predictors of metabolic dysfunction-associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adults.
    Perumpail BJ; Manikat R; Wijarnpreecha K; Cholankeril G; Ahmed A; Kim D
    J Pediatr Gastroenterol Nutr; 2024 Jul; 79(1):110-118. PubMed ID: 38623942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between long working hours and metabolic dysfunction-associated steatotic liver disease: a nationwide population-based study in Korea.
    Baek SU; Won JU; Lee YM; Yoon JH
    Public Health; 2024 Jul; 232():188-194. PubMed ID: 38796916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Greater hepatic lipid saturation is associated with impaired glycaemic regulation in men with metabolic dysfunction-associated steatotic liver disease but is not altered by 6 weeks of exercise training.
    Willis SA; Malaikah S; Bawden SJ; Sherry AP; Sargeant JA; Coull NA; Bradley CR; Rowlands A; Naim I; Ennequin G; Yates T; Waheed G; Gowland P; Stensel DJ; Webb DR; Davies MJ; Aithal GP; King JA
    Diabetes Obes Metab; 2024 Sep; 26(9):4030-4042. PubMed ID: 38978184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus.
    Mantovani A; Morieri ML; Aldigeri R; Palmisano L; Masulli M; Bonomo K; Baroni MG; Cossu E; Cimini FA; Cavallo G; Buzzetti R; Mignogna C; Leonetti F; Bacci S; Trevisan R; Pollis RM; Cas AD; de Kreutzenberg SV; Targher G
    Diabetes Metab; 2024 Jan; 50(1):101497. PubMed ID: 37992857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated LDL-c may warn of the risk of gallbladder stones in the patients with metabolic dysfunction-associated steatotic liver disease: A case-control study.
    Zhao G; Shi R; Ma M; Lin H; Zhang J; Sheng B
    Clin Res Hepatol Gastroenterol; 2024 Jun; 48(6):102363. PubMed ID: 38703815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of
    Elmansoury N; Megahed AA; Kamal A; El-Nikhely N; Labane M; Abdelmageed M; Daly AK; Wahid A
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between HbA1c and continuous glucose monitoring metrics of glycaemic control and glucose variability in a large cohort of children and adolescents with type 1 diabetes.
    Piona C; Marigliano M; Mozzillo E; Rosanio F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Piccinno E; Delvecchio M; Maffeis C
    Diabetes Res Clin Pract; 2021 Jul; 177():108933. PubMed ID: 34216681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practice Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease by the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition (ISPGHAN).
    Sood V; Alam S; Nagral A; Srivastava A; Deshmukh A; Bavdekar A; Acharyya BC; Geetha SM; Gupte G; Bhatia I; Tiwari K; Bharadia L; Sathiyasekaran M; Kaur P; Khanna R; Shrivastava R; Poyekar S; Pandey S; Ramakrishna SH; Kinjawadekar U; Borkar V; Sivaramakrishnan VM; Kohli R; Matthai J; Dhawan A
    Indian Pediatr; 2024 Oct; 61(10):919-934. PubMed ID: 39297398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and predictive features of metabolic dysfunction-associated steatotic liver disease in type 1 diabetes.
    Fuhri Snethlage CM; Meijnikman AS; Mak AL; Rampanelli E; Voermans B; Callender CAK; de Groen P; Roep BO; van Raalte DH; Knop FK; Holleboom AG; Nieuwdorp M; Hanssen NMJ
    Eur J Endocrinol; 2024 May; 190(5):391-400. PubMed ID: 38679966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HbA1c but not diabetes duration predicts increased arterial stiffness in adolescents with poorly controlled type 1 diabetes.
    Obermannova B; Petruzelkova L; Sulakova T; Sumnik Z
    Pediatr Diabetes; 2017 Jun; 18(4):304-310. PubMed ID: 27075550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diet, physical, and biochemical characteristics of children and adolescents with type 1 diabetes: relationship between dietary fat and glucose control.
    Maffeis C; Morandi A; Ventura E; Sabbion A; Contreas G; Tomasselli F; Tommasi M; Fasan I; Costantini S; Pinelli L
    Pediatr Diabetes; 2012 Mar; 13(2):137-46. PubMed ID: 21672107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of steatotic liver disease (MASLD, MetALD, ALD) and clinically significant fibrosis in US adolescents : Authors' name.
    Shi GX; Qian YS; Jiang CM; Liu ZZ; Yang X; Xu YW; Jin SS; Chu JG; Qian GQ; Yang NB
    Sci Rep; 2024 Oct; 14(1):25724. PubMed ID: 39468178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycaemic control in type 1 diabetes mellitus among children and adolescents in a resource limited setting in Dar es Salaam - Tanzania.
    Noorani M; Ramaiya K; Manji K
    BMC Endocr Disord; 2016 May; 16(1):29. PubMed ID: 27246505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Metabolic Dysfunction-Associated Steatotic Liver Disease/Non-alcoholic Fatty Liver Disease With Type 2 Diabetes Mellitus: A Case-Control Study in a Tertiary Care Hospital in Pakistan.
    Zahoor F; Saeed NU; Javed S; Sadiq HZ; Mand Khan F; Haider M; Shafqat MN; Maqbool A; Chaudhry A
    Cureus; 2023 Oct; 15(10):e47240. PubMed ID: 38021965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Dysfunction-Associated Steatotic Liver Disease in Japan: Prevalence Trends and Clinical Background in the 10 Years before the Coronavirus Disease 2019 Pandemic.
    Sato A; Oomori Y; Nakano R; Matsuura T
    Medicina (Kaunas); 2024 Aug; 60(8):. PubMed ID: 39202611
    [No Abstract]   [Full Text] [Related]  

  • 20. Association between remnant cholesterol and metabolic dysfunction-associated steatotic liver disease in the elderly.
    Lan Y; Guo Z; Dai J; Chen K; Chen Y
    Dig Liver Dis; 2024 Sep; 56(9):1557-1564. PubMed ID: 38582712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.